GUFICBIO - Gufic Biosciences

Gufic Biosciences

GUFICBIO · Pharma > Pharmaceuticals & Drugs · Chairman: Jayesh P Choksi · MD: Jayesh P Choksi · Listing date: Oct. 20, 2004 · Employees: 1247 · Mumbai · http://gufic.com

Stock Price vs Company Growth

0.7%

6.9%

9.6%

7.2%

16.2%

16.5%

45.9%

10y

37.7%

all

21.3%

🤔 How to analyze this graph?

Last Traded Price

₹ 374 0.7%

285

410

Company Overview

Sales

810 Cr

Growth: 4.0%

Profit after Tax

82 Cr

Growth: -3.5%

Small Cap

3,753 Cr

P/E: 45.8x

Industry P/E: 33.0x

Fundamentals

Sales (Cr)	₹ 810
Growth	4.0%
EBITDA	17.6%
P/S	4.6x
Dividend	0.0%
P/E	45.8x
Book Value	₹ 1
PEG Ratio	11.4x
ROE	817.5%
P/B	N/A

Shareholding Pattern

Institutions

Sbi Healthcare Opportunities Fund

2.61 %

Promoters

Mr. Jayesh P. Choksi

25.95 %

Zircon Teconica Private Limited (Formely Known As Zircon Finance & Leasing Private Limited)

21.17 %

Gufic Private Limited

10.51 %

Mr. Pranav J. Choksi

7.5 %

Others

Vipula Jayesh Choksi

10.35 %

Jagdish N Master

1.65 %

Iepf

0.21 %

Increase Decrease No change

Company Profile Detailed

The company is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.Products of the companyPharmaceuticalHerbalAPI / Bulk DrugsPersonal careInternationalHistory and milestonePast InitiativesFirst Indian to produce Doxycycline Inj.First Indian company to make Liquid Oxytetracycline Inj.

Belongs to (8 Indices) view more

Investors (46)

icici.pr...

sbi.acti...

abhay4

Followers (8)

indrajee...

nihal

mrinmoy4